Natus Medical (BABY) Tops Q2 EPS by 4c; Narrows Outlook
Tweet Send to a Friend
Natus Medical (NASDAQ: BABY) reported Q2 EPS of $0.34, $0.04 better than the analyst estimate of $0.30. Revenue for the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
